Zhang Lu, Yang Tianyu, Zhang Yao, Yan Jiahui, Li Jiaguo, Xu Wenfeng, Zhu Weimin, Wang Xinhao
Drug Discovery and Development, Shanghai Cell Therapy Group Co. Ltd., Shanghai, China.
Drug Discovery and Development, Chantibody Therapeutics, Menlo Park, CA, United States.
Front Immunol. 2025 Aug 15;16:1647230. doi: 10.3389/fimmu.2025.1647230. eCollection 2025.
VHHs, or nanobodies, are distinguished by their compact size, high stability, and unique ability to selectively target specific epitopes. The CDR3 region in VHHs, which plays a crucial role in antigen binding, exhibits significant diversity and varies among species.
This study systematically examined CDR3 length dependent patterns by analyzing NGS sequences from the PBMCs of Alpacas, Llamas and Bactrians, in conjunction with VHH structure data from the public database.
VHHs from Alpacas and Llamas exhibited similar CDR3 length distributions, while Bactrian VHHs displayed significantly longer but narrower length distribution. Key sequence, structural, and VHH/antigen interaction characteristics correlated with CDR3 length were identified. Specifically, longer CDR3s were associated with a lower net charge, reduced surface hydrophobicity, and enhanced interactions with other VHH regions. Structural analyses revealed that longer CDR3s tended to adopt bent conformations with increased helical and coil structures, whereas shorter CDR3s favored extended conformations and β-sheets. Associations between CDR3 length and amino acid usage patterns within VHH sequences were also observed, including preferences at various sites and in antigen interactions. Notably, species-specific differences were apparent, with Alpaca and Llama VHHs showing more pronounced CDR3 length-dependent patterns than those from Bactrians.
These findings highlight the significant impact of CDR3 length on VHH sequence, structure, and antigen interaction characteristics, providing valuable insights for VHH engineering, synthetic library design, and the development of therapeutic nanobodies optimized for targeting diverse epitopes.
VHH(即纳米抗体)以其紧凑的尺寸、高稳定性以及选择性靶向特定表位的独特能力而著称。VHH中的互补决定区3(CDR3)在抗原结合中起关键作用,表现出显著的多样性且因物种而异。
本研究通过分析羊驼、美洲驼和双峰驼外周血单核细胞(PBMC)的二代测序(NGS)序列,并结合公共数据库中的VHH结构数据,系统地研究了CDR3长度依赖性模式。
羊驼和美洲驼的VHH表现出相似的CDR3长度分布,而双峰驼的VHH则显示出明显更长但更窄的长度分布。确定了与CDR3长度相关的关键序列、结构以及VHH/抗原相互作用特征。具体而言,较长的CDR3与较低的净电荷、降低的表面疏水性以及与其他VHH区域增强的相互作用相关。结构分析表明,较长的CDR3倾向于采用具有增加的螺旋和卷曲结构的弯曲构象,而较短的CDR3则有利于伸展构象和β折叠。还观察到CDR3长度与VHH序列内氨基酸使用模式之间的关联,包括不同位点以及抗原相互作用中的偏好。值得注意的是,物种特异性差异明显,羊驼和美洲驼的VHH比双峰驼的VHH表现出更明显的CDR3长度依赖性模式。
这些发现突出了CDR3长度对VHH序列、结构和抗原相互作用特征的重大影响,为VHH工程、合成文库设计以及针对不同表位优化的治疗性纳米抗体的开发提供了有价值的见解。